Ling Qin
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Ling Qin has a total of 68 co-authors. Here are the top co-authors by number of shared publications:
Hongwei Shao
5 shared publicationsWenxue Tong
5 shared publicationsYuantao Zhang
Musculoskeletal Research Laboratory, Centre for Musculoskeletal Degeneration & Regeneration, Department of Orthopaedics & Traumatology, Faculty of Medicine, The Chinese University of Hong Kong, Hong Kong Special Administrative Region of China
4 shared publicationsJiankun Xu
3 shared publicationsLizhen Zheng
3 shared publicationsShunxiang Xu
3 shared publications
Latest Publications
- Open Access
Green Radiative Cooling and Antimicrobial Materials Based on Polylactic Acid Oligomer Hexagonal Microspheres
Thermal management relying on passive radiative cooling materials can result in remarkable energy savings and greenhouse gas emissions reductions compared with traditional air conditioner-based cooling. However, few of these materials are degradable; thus, their disposal may generate a new environmental problem. At the same time, the COVID-19 pandemic and other infectious diseases have raised requirements for hygienic and antimicrobial performance. In this work, we use a facile solvent evaporation method to prepare a novel hierarchically porous polylactic acid oligomer (PLAO) coating that exhibits a radiative cooling effect, broad-spectrum antimicrobial properties, and degradability (with a degradation rate of 99.5% after 28 days). The radiative cooling effect is attributed to the hexagonal microsphere geometry and nanotexture of the polylactic acid oligomer (PLAO) crystals, which enhance reflectivity in the solar spectrum through a multiple scattering effect and exhibit high emissivity in the mid-infrared atmospheric window. The hierarchically porous PLAO coating material achieves an apparent temperature reduction of 6.8 °C under solar-spectrum irradiation (AM 1.5). The material also shows broad-spectrum antimicrobial and antiviral properties against coronaviruses (including the COVID-19 virus), with a reduction rate of 99.99% after 20 min; Gram-positive and Gram-negative bacteria, with a reduction rate of 99.99% after 1 h; fungi, with a reduction rate of 98.4% after 1 h; and multidrug-resistant bacteria, against which it produces a 0.22 cm inhibition ring after 12 h.
Open AccessGreen Radiative Cooling and Antimicrobial Materials Based on Polylactic Acid Oligomer Hexagonal Microspheres
Thermal management relying on passive radiative cooling materials can result in remarkable energy savings and greenhouse gas emissions reductions compared with traditional air conditioner-based cooling. However, few of these materials are degradable; thus, their disposal may generate a new environmental problem. At the same time, the COVID-19 pandemic and other infectious diseases have raised requirements for hygienic and antimicrobial performance. In this work, we use a facile solvent evaporation method to prepare a novel hierarchically porous polylactic acid oligomer (PLAO) coating that exhibits a radiative cooling effect, broad-spectrum antimicrobial properties, and degradability (with a degradation rate of 99.5% after 28 days). The radiative cooling effect is attributed to the hexagonal microsphere geometry and nanotexture of the polylactic acid oligomer (PLAO) crystals, which enhance reflectivity in the solar spectrum through a multiple scattering effect and exhibit high emissivity in the mid-infrared atmospheric window. The hierarchically porous PLAO coating material achieves an apparent temperature reduction of 6.8 °C under solar-spectrum irradiation (AM 1.5). The material also shows broad-spectrum antimicrobial and antiviral properties against coronaviruses (including the COVID-19 virus), with a reduction rate of 99.99% after 20 min; Gram-positive and Gram-negative bacteria, with a reduction rate of 99.99% after 1 h; fungi, with a reduction rate of 98.4% after 1 h; and multidrug-resistant bacteria, against which it produces a 0.22 cm inhibition ring after 12 h.
- Open Access
- 1 October 2026
- Published by MDPI AG in Preprints.org
Green Radiative Cooling and Antimicrobial Materials Based on Polylactic Acid Oligomer Hexagonal Microspheres
Thermal management by passive radiative cooling materials can save energy and reduce emission of green-house gas remarkably compared with traditional air-conditioner cooling. However, few of these materials are degradable, thus their disposal may lead to another environmental problem. Meanwhile, the COVID-19 pandemic and other infectious diseases have raised the requirement of hygienic and antimicrobial performance. This work reports a discovery that polylactic acid oligomer (PLAO) material possesses radiative cooling effect, wide-spectrum antimicrobial property and degradability, simultaneously. The radiative cooling effect is attribute to the hexagonal microsphere geometry and nanotexture of polylactic acid oligomer (PLAO) crystals, which enhance the reflectivity in the solar spectrum through multiple scattering effect and exhibit high emissivity in the mid-infrared atmospheric window. Hierarchically porous PLAO coating material realizes an apparent temperature reduction of 6.8 ℃ under irradiation of solar spectrum (AM 1.5). The material also shows wide-spectrum antimicrobial and anti-viral properties against coronaviruses (including COVID-19 virus), gram-positive bacteria, gram-negative bacteria, fungi and multidrug resistant bacteria.
- 1 October 2026
- Published by MDPI AG in Preprints.org
Open AccessGreen Radiative Cooling and Antimicrobial Materials Based on Polylactic Acid Oligomer Hexagonal Microspheres
Thermal management by passive radiative cooling materials can save energy and reduce emission of green-house gas remarkably compared with traditional air-conditioner cooling. However, few of these materials are degradable, thus their disposal may lead to another environmental problem. Meanwhile, the COVID-19 pandemic and other infectious diseases have raised the requirement of hygienic and antimicrobial performance. This work reports a discovery that polylactic acid oligomer (PLAO) material possesses radiative cooling effect, wide-spectrum antimicrobial property and degradability, simultaneously. The radiative cooling effect is attribute to the hexagonal microsphere geometry and nanotexture of polylactic acid oligomer (PLAO) crystals, which enhance the reflectivity in the solar spectrum through multiple scattering effect and exhibit high emissivity in the mid-infrared atmospheric window. Hierarchically porous PLAO coating material realizes an apparent temperature reduction of 6.8 ℃ under irradiation of solar spectrum (AM 1.5). The material also shows wide-spectrum antimicrobial and anti-viral properties against coronaviruses (including COVID-19 virus), gram-positive bacteria, gram-negative bacteria, fungi and multidrug resistant bacteria.
- Open Access
- 9 July 2026
- Published by Elsevier in SSRN Electronic Journal
Building a medical products regulatory authority in Hong Kong: Why medical devices must lead the 2025–2026 reform agenda
Hong Kong's Department of Health announced in June 2025 a timetable for establishing the Centre for Medical Products Regulation (CMPR) by end 2026, including a phased primary evaluation roadmap for drugs (2026–2030). The statutory framework for medical devices remains in the drafting stage with no confirmed timetable, a pharmaceutical-first asymmetry that is the central policy concern. The existing Medical Device Administrative Control System provides voluntary listing via leveraged foreign approval or a conformity assessment body (CAB) pathway, but neither constitutes sovereign statutory approval. CAB certificates lack legal enforceability and cross-jurisdictional recognition, rendering the pathway commercially inert for locally developed innovations. Medical devices characterised by shorter development cycles, smaller clinical trial requirements, and alignment with Hong Kong's translational research strengths in the Greater Bay Area represent the highest-return near-term regulatory priority, yet receive subordinate treatment within the current reform. Dedicated legislation, institutional transition of the CAB into a statutory framework, and a confirmed device-track timetable are the three prerequisite actions. A constitutional and technical framework for CMPR–NMPA harmonization, grounded in mutual recognition under the "one country, two systems" architecture and operationalized through aligned dossier requirements is proposed as a novel contribution.
- 9 July 2026
- Published by Elsevier in SSRN Electronic Journal
Open AccessBuilding a medical products regulatory authority in Hong Kong: Why medical devices must lead the 2025–2026 reform agenda
Hong Kong's Department of Health announced in June 2025 a timetable for establishing the Centre for Medical Products Regulation (CMPR) by end 2026, including a phased primary evaluation roadmap for drugs (2026–2030). The statutory framework for medical devices remains in the drafting stage with no confirmed timetable, a pharmaceutical-first asymmetry that is the central policy concern. The existing Medical Device Administrative Control System provides voluntary listing via leveraged foreign approval or a conformity assessment body (CAB) pathway, but neither constitutes sovereign statutory approval. CAB certificates lack legal enforceability and cross-jurisdictional recognition, rendering the pathway commercially inert for locally developed innovations. Medical devices characterised by shorter development cycles, smaller clinical trial requirements, and alignment with Hong Kong's translational research strengths in the Greater Bay Area represent the highest-return near-term regulatory priority, yet receive subordinate treatment within the current reform. Dedicated legislation, institutional transition of the CAB into a statutory framework, and a confirmed device-track timetable are the three prerequisite actions. A constitutional and technical framework for CMPR–NMPA harmonization, grounded in mutual recognition under the "one country, two systems" architecture and operationalized through aligned dossier requirements is proposed as a novel contribution.
- Open Access
- 7 May 2026
- Published by Elsevier in Biomaterials
- Vol. 334, 124287
Hydrogen reshapes the senescent microenvironment of callus to enhance the healing of anti-osteoporotic-drug-induced atypical femoral fracture
- 7 May 2026
- Published by Elsevier in Biomaterials
- Vol. 334, 124287
Open AccessHydrogen reshapes the senescent microenvironment of callus to enhance the healing of anti-osteoporotic-drug-induced atypical femoral fracture
- Open Access
- 14 February 2026
- Published by Elsevier in Biomaterials
- Vol. 330, 124063
Macrophages: Redefining extracellular matrix architecture through phenotypic switches as therapeutic targets
- 14 February 2026
- Published by Elsevier in Biomaterials
- Vol. 330, 124063
Open AccessMacrophages: Redefining extracellular matrix architecture through phenotypic switches as therapeutic targets
- Open Access
- 29 July 2025
- Published by Wiley in Interdisciplinary Materials
- Vol. 4 (5) , 745-762
Magnesium Silicate Composite Patch With Neurovascular Regenerative Properties Promotes Diabetic Wound Healing in Mice
Given the confluence of dysregulated inflammation, vasculopathy, and neuropathy, diabetic wounds pose a significant clinical challenge. Commercially available wound dressings often lack sufficient bioactivity, failing to meet clinical demands. Herein, we developed a PCL‐PLLA‐MgSiO3 (PP‐MgSi) patch with promising therapeutic effects. The PP‐MgSi composite patch was manufactured via electrospinning and characterized by controllable degradation and local release of Mg2+ and SiO32−. The patch showed favorable in vitro biocompatibility and bioactivity, notably increased angiogenesis, myelination, and neurite outgrowth. In type 2 diabetic mice, the PP‐MgSi patch exhibited MgSi dose‐dependent effects on enhancing diabetic wound healing by modulating the expression of TNF‐α, iNOS, and CD206 to balance inflammation, while boosting CD31 and β3‐tubulin levels to promote neurovascularization. With the significant suppression of pro‐inflammatory‐related TNF and IL‐17 pathways, while activating the peripheral nerve‐associated axon guidance pathway, blood vessel‐associated HIF‐1α and VEGF pathways, the PP‐MgSi patch ultimately achieved accelerated healing compared to the control group. Ultimately, the PP‐MgSi patch exhibited an accelerated repair rate, with comparable neovascularization and superior peripheral nerve regeneration capacity compared to three representative commercially available products. This proof‐of‐concept work presents a promising bioactive PP‐MgSi patch for future clinical diabetic wound management, particularly in terms of its neurovascular network recovery properties.
- 29 July 2025
- Published by Wiley in Interdisciplinary Materials
- Vol. 4 (5) , 745-762
Open AccessMagnesium Silicate Composite Patch With Neurovascular Regenerative Properties Promotes Diabetic Wound Healing in Mice
Given the confluence of dysregulated inflammation, vasculopathy, and neuropathy, diabetic wounds pose a significant clinical challenge. Commercially available wound dressings often lack sufficient bioactivity, failing to meet clinical demands. Herein, we developed a PCL‐PLLA‐MgSiO3 (PP‐MgSi) patch with promising therapeutic effects. The PP‐MgSi composite patch was manufactured via electrospinning and characterized by controllable degradation and local release of Mg2+ and SiO32−. The patch showed favorable in vitro biocompatibility and bioactivity, notably increased angiogenesis, myelination, and neurite outgrowth. In type 2 diabetic mice, the PP‐MgSi patch exhibited MgSi dose‐dependent effects on enhancing diabetic wound healing by modulating the expression of TNF‐α, iNOS, and CD206 to balance inflammation, while boosting CD31 and β3‐tubulin levels to promote neurovascularization. With the significant suppression of pro‐inflammatory‐related TNF and IL‐17 pathways, while activating the peripheral nerve‐associated axon guidance pathway, blood vessel‐associated HIF‐1α and VEGF pathways, the PP‐MgSi patch ultimately achieved accelerated healing compared to the control group. Ultimately, the PP‐MgSi patch exhibited an accelerated repair rate, with comparable neovascularization and superior peripheral nerve regeneration capacity compared to three representative commercially available products. This proof‐of‐concept work presents a promising bioactive PP‐MgSi patch for future clinical diabetic wound management, particularly in terms of its neurovascular network recovery properties.
- Open Access
- 19 May 2025
- Published by Elsevier in Biomaterials
- Vol. 323, 123428
Hydrogen activates ACOD1-itaconate pathway to ameliorate steroid-associated osteonecrosis
- 19 May 2025
- Published by Elsevier in Biomaterials
- Vol. 323, 123428
Open AccessHydrogen activates ACOD1-itaconate pathway to ameliorate steroid-associated osteonecrosis
- Open Access
- 27 November 2023
- Published by Wiley in Advanced Functional Materials
- Vol. 34 (9)
Green‐Prepared Magnesium Silicate Sprays Enhance the Repair of Burn‐Skin Wound and Appendages Regeneration in Rats and Minipigs
Bioceramics provide promising tactics for wound healing, yet the on‐shelf products are still unmet, especially for skin appendages regeneration. Herein, the inorganic magnesium silicate sprays (MSS) as mineral factors to overcome the existing challenges is proposed. Results indicate MSS can be synthesized by a green method without organic solvents, templates, calcination, and harmful by‐products. With amorphous phase, nanoscale, and high specific surface area, MSS reveal an improved pH‐responsive degradability and excellent bioactivity for cell proliferation and migration. In rats, MSS display a dose‐dependent effect on accelerating burn‐wound repair via regulating the expressions of iNOS and IL‐10 to attenuate inflammation, elevating the expressions of CD31 and α‐SMA to improve vascularization, and boosting collagen deposition without ectopic calcification. The released Mg and Si ions synergistically potentiate the expressions of Gap43, Tubb3, and K19, suggesting the regeneration of peripheral nerves and hair follicles. These superior features are further verified by comparisons with commercial products, Dermlin® and 45S5 bioglass®, in both rats and minipigs. Motivated by these findings, three MSS‐based formulations of band‐aid patch, adhesive hydrogel, and antibacterial sprays are devised for specific scenarios. Taken together, this proof‐of concept study provides a promising bioactive mineral for future clinical skin wound repair and functional appendages regeneration.
- 27 November 2023
- Published by Wiley in Advanced Functional Materials
- Vol. 34 (9)
Open AccessGreen‐Prepared Magnesium Silicate Sprays Enhance the Repair of Burn‐Skin Wound and Appendages Regeneration in Rats and Minipigs
Bioceramics provide promising tactics for wound healing, yet the on‐shelf products are still unmet, especially for skin appendages regeneration. Herein, the inorganic magnesium silicate sprays (MSS) as mineral factors to overcome the existing challenges is proposed. Results indicate MSS can be synthesized by a green method without organic solvents, templates, calcination, and harmful by‐products. With amorphous phase, nanoscale, and high specific surface area, MSS reveal an improved pH‐responsive degradability and excellent bioactivity for cell proliferation and migration. In rats, MSS display a dose‐dependent effect on accelerating burn‐wound repair via regulating the expressions of iNOS and IL‐10 to attenuate inflammation, elevating the expressions of CD31 and α‐SMA to improve vascularization, and boosting collagen deposition without ectopic calcification. The released Mg and Si ions synergistically potentiate the expressions of Gap43, Tubb3, and K19, suggesting the regeneration of peripheral nerves and hair follicles. These superior features are further verified by comparisons with commercial products, Dermlin® and 45S5 bioglass®, in both rats and minipigs. Motivated by these findings, three MSS‐based formulations of band‐aid patch, adhesive hydrogel, and antibacterial sprays are devised for specific scenarios. Taken together, this proof‐of concept study provides a promising bioactive mineral for future clinical skin wound repair and functional appendages regeneration.